Erin VanDyke: Shifting Attention Upstream in VTE Care Through NBCA Centers of Excellence
Erin VanDyke, Vice President of National Blood Clot Alliance Centers of Excellence, shared a post on LinkedIn:
“Pulmonary embolism (PE) often takes the spotlight in venous thromboembolism (VTE) discussions, and understandably so—it is frequently life-threatening. But the most common precursor to PE is deep vein thrombosis (DVT), and this is where we have a real opportunity to intervene earlier.
- Up to 50% of patients with PE also have concomitant DVT
- An estimated 900,000 Americans are affected by VTE each year, with 100,000+ deaths annually—many preventable
Despite these numbers, resources and infrastructure to support DVT identification, follow-up, and longitudinal care remain limited compared to PE. Clinical pathways vary widely, and standardized approaches are often lacking.
National Blood Clot Alliance is leading national efforts across the full VTE disease state—PE and DVT alike. Through initiatives like the NBCA Centers of Excellence program, we are partnering with hospitals and clinical teams to:
- Standardize care protocols
- Strengthen follow-up pathways
- Provide education and resources that support providers and patients across the spectrum of VTE
We encourage centers to explore the NBCA COE program and stay tuned for new initiatives launching to support community DVT centers.
Our collective challenge—and opportunity—is to shift attention upstream. By addressing DVT earlier and more consistently, we can reduce downstream PE and ultimately save lives.”
More information here.
Keep up with Hemostasis Today.
-
Jan 27, 2026, 14:06Dmitrii V Kalinin Shares A PhD Opportunity: Hardiman Scholarship
-
Jan 27, 2026, 13:48Filippo Cademartiri: 3 Biomarkers Are Better Than 1: Refining ASCVD Risk in MESA
-
Jan 27, 2026, 12:27Martin Haluzík on Residual Cardiovascular Risk in Coronary Artery Disease
-
Jan 27, 2026, 12:18Stuart Phillips: Strong Bodies Are Good, Informed Bodies Are Better!
-
Jan 27, 2026, 12:07Daniel Torrent: This Should Be An Ice Cold Take… But Veins Aren’t Arteries
-
Jan 27, 2026, 09:17Paolo Zamboni on CCSVI Associated to Multiple Sclerosis
-
Jan 27, 2026, 09:02Rowan Paul: Platelet Dose Determines Success in PRP Therapy
-
Jan 27, 2026, 08:48Uriel Suárez: Hemi‐Orolingual Angioedema in a Patient With VEXAS Syndrome
-
Jan 27, 2026, 08:23Rossella Crescitelli on Platelets’ and PEVs’ Association with Lung Cancer Metastases
